Questo è quello che abbiamo trovato per te
Mission Statement: To advance the equitable, person-centered, and evidence-based practice of internal medicine through publication of scientifically rigorous, innovative, and inclusive research, review, and commentary that informs dialogue and action with clinical, public health, and policy impact.
Mission Statement: JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. The journal also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists. JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.
Mission Statement: JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians and researchers in psychiatry, mental health, behavioral science, and allied fields. The journal seeks to inform its readers, to stimulate discussion into the nature, causes, treatment, and public health importance of mental illness, and to promote equity and justice for those affected by mental illness and for society.
Recently, Kirsten Bibbins-Domingo, MD, PhD, MAS, Editor of JAMA and the JAMA Network, and the editors and diversity, equity, and inclusion (DEI) editors from JAMA and the JAMA Network specialty journals, including JAMA Psychiatry, coauthored an article affirming the JAMA Network’s commitment to DEI and reviewing markers of progress in the makeup of the editorial boards across the network. For JAMA Psychiatry specifically, more than half of the respondents who disclosed their gender were women, a proportion reflecting the gender breakdown of the US and more balanced than that in academic psychiatry. In terms of ethnic origins or ancestry, nearly three-quarters had Eastern or Western European ancestry, with Central American and Caribbean ancestry a distant second. For race, two-thirds of respondents endorsed White race, with Asian or Pacific Islander and Black tied for distant second. This pattern is reflective of psychiatry in general, with racial and ethnic minoritized communities underrepresented among academic faculty. Among JAMA Psychiatry editorial board members, many ethnic and racial categories had small sample sizes such that reporting specific rates could lead to identification of those individuals, which is why they are not specifically discussed here. Despite this, we aim for transparency in the collection and analysis of these data as we continue with ongoing DEI efforts, and we hold ourselves accountable.
JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.
Mission Statement: JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians and researchers in psychiatry, mental health, behavioral science, and allied fields. The journal seeks to inform its readers, to stimulate discussion into the nature, causes, treatment, and public health importance of mental illness, and to promote equity and justice for those affected by mental illness and for society.
Mission Statement: To advance the equitable, person-centered, and evidence-based practice of internal medicine through publication of scientifically rigorous, innovative, and inclusive research, review, and commentary that informs dialogue and action with clinical, public health, and policy impact.
Mission Statement: JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. The journal also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists. JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.
The Special Communication “Causal Inferences About the Effects of Interventions From Observational Studies in Medical Journals,” published in this issue of JAMA, provides a rationale and framework for considering causal inference from observational studies published by medical journals. Our intent is to invite discussion of this framework, explore its application in the context of specific study designs, and actively examine how this framework could be implemented and used by authors, peer reviewers, and editors of medical journals, including JAMA and the journals of the JAMA Network. Our overarching goal is to ensure that findings from observational designs may be appropriately interpreted in thoughtful and circumspect manners and applied by readers, other researchers, and clinicians, with the ultimate goal of improving patient care and public and global health.
